| Name | [4-methyl-2-[3-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methanol |
|---|---|
| Synonyms |
5-(Hydroxymethyl)-4-methyl-2-[3-(trifluoromethyl)phenyl]-1,3-thiazole
{4-methyl-2-[3-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methanol (4-methyl-2-(3-(trifluoromethyl)phenyl)thiazol-5-yl)methanol |
| Molecular Formula | C12H10F3NOS |
|---|---|
| Molecular Weight | 273.27400 |
| Exact Mass | 273.04400 |
| PSA | 61.36000 |
| LogP | 3.62960 |
| HS Code | 2934100090 |
|---|
|
~48%
668477-94-9 |
| Literature: Takeda Pharmaceutical Company Limited Patent: EP2264017 A1, 2010 ; Location in patent: Page/Page column 171 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |